NOT-CA-03-031: NOTICE OF AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS FOR DISSEMINATING EVIDENCE

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

NOTICE OF AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS FOR DISSEMINATING 
EVIDENCE - BASED INTERVENTION RESEARCH PRODUCTS

RELEASE DATE:  May 12, 2003

NOTICE:  NOT-CA-03-031

National Cancer Institute (NCI)
 (http://cancer.gov/)

The National Cancer Institute's (NCI) Division of Cancer Control and 
Population Sciences (DCCPS) announces  the availability of funds for 
supplemental applications to NCI-funded research projects supported by 
R01, P01, P50, U01 and U19 grant mechanisms.   Most researchers who 
propose to develop and test cancer control interventions either 
explicitly or implicitly intend to disseminate the interventions within 
the populations from which the sample is drawn if the interventions 
prove efficacious. However, without financial support for the costs of 
dissemination, active dissemination rarely occurs.  The purpose of 
these supplements is to fund the dissemination of promising 
intervention programs and products.  This includes interventions where 
statistical significance and potential public health/clinical 
significance suggest the merits of dissemination to the broader 
population from which the intervention study sample was originally 
drawn.  The supplement also may support cost-effectiveness evaluations 
of interventions, qualitative and quantitative research needed to adapt 
intervention products for use after formal research evaluation has 
ended and dissemination of intervention products.

These supplements have been designed to provide one-year funding to 
cancer control investigators whose intervention efficacy data have been 
analyzed, who are in the final years of their R01, P01, P50, U01 or U19 
awards or are conducting follow-up peer-reviewed research related to 
the intervention program proposed for dissemination.   Intervention 
research across the cancer control continuum that may be eligible for 
these supplements, includes: tobacco use prevention and cessation, 
promotion of appropriate changes in diet and physical activity, 
reduction of sun exposure and UV radiation exposure, facilitating 
informed decisions about genetic testing for cancer susceptibility, 
enhancing screening for breast, cervix and colorectal cancers, quality 
of care as well as improving coping skills and quality of life for 
cancer survivors and their families.

Detailed instructions for applying for this supplement can be found at: 
http://www.dccps.cancer.gov/funding_inst_sup.html

INQUIRIES

Direct inquiries concerning the programmatic and review matters to:

Jon F. Kerner, Ph.D.
Assistant Deputy Director for Research Dissemination and Diffusion
Division of Cancer Control and Population Sciences
6130 Executive Boulevard
Executive Plaza North, Room 6144
Rockville, MD  20852
Telephone: 301-594-7294
E-mail:  [email protected]

Direct inquiries regarding fiscal matters should be made to:

Ms. Crystal Wolfrey
Grants Administration Branch
6120 Executive Boulevard
Executive Plaza South, Room 243
Rockville, MD  20852
Telephone:  301-496-8634
E-mail:  [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices